{
  "company": {
    "name": "Luxna Biotech Co., Ltd.",
    "website": "https://luxnabiotech.co.jp/",
    "record": "https://startuphistory.org/c/luxnabiotech.co.jp"
  },
  "status": null,
  "history_since": "2026-11-12T11:28:43.016Z",
  "baseline": {
    "snapshot_id": "256b79ee730bcb17547c5454a78fbdff1881fd34ef5ead351d62d273bf7003a9",
    "observed_at": "2026-11-12T11:28:43.016Z",
    "headline": null,
    "description": "ルクサナバイオテク（Luxna Bioetch）はアカデミアで蓄積された核酸医薬品要素技術（架橋型修飾核酸・毒性低減技術）を基礎として、より安全かつ効果的な核酸医薬品の実用化を進めて医薬品素材提供やアカデミアの創薬研究を加速させることを通じ、アンメットメディカルニーズに応えることを目指します。【社名の由来】修飾核酸群（XNA）を活用した核酸医薬品の開発を進めることで、まだ治療薬がなく苦しんでいる患",
    "evidence": "https://luxnabiotech.co.jp/",
    "evidence_kind": "live_capture",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-12T11:28:43.016Z",
  "live_status": null,
  "messaging": [],
  "changes": [],
  "update": null,
  "same_space": [
    {
      "name": "Lexeo Therapeutics",
      "record": "https://startuphistory.org/c/lexeotx.com",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "CCX Pharma",
      "record": "https://startuphistory.org/c/ccx.tech",
      "basis": "description_similarity",
      "category": null
    },
    {
      "name": "ProLynx",
      "record": "https://startuphistory.org/c/prolynxinc.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    },
    {
      "name": "BlossomHill Therapeutics",
      "record": "https://startuphistory.org/c/bhtherapeutics.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    },
    {
      "name": "Star Therapeutics",
      "record": "https://startuphistory.org/c/star-therapeutics.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    },
    {
      "name": "Uncommon Therapeutics",
      "record": "https://startuphistory.org/c/uncommontherapeutics.com",
      "basis": "category",
      "category": "Early-stage small-molecule and antibody drugs"
    }
  ],
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Luxna Biotech Co., Ltd.” company record, https://startuphistory.org/c/luxnabiotech.co.jp"
}